Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR

Therapuetic Areas:Endocrinology
Age Range:21 - 59
Start Date:December 2005

Use our guide to learn which trials are right for you!

Phase I Study of Transdermal Testosterone Gel and Its Effect on Erection Quality as Measured by a Digital Inflection Rigidometer (DIR)

Low testosterone may be responsible for "soft" erections in men. The purpose of our study is
to see whether the daily application of a testosterone gel to raise testosterone levels will
also increase the "hardness" of a man's erection.

Inclusion Criteria:

- Testosterone <350 ng/dL,

- 21-59 years of age,

- BMI <30

Exclusion Criteria:

- Those with carcinoma of the breast or known or suspected carcinoma of the prostate or
with known hypersensitivity to any of the ingredients in AndroGel.

- Men will be excluded if they have unstable angina, hypertension, diabetes, heart
failure, or coronary artery disease.

- Men will agree to discontinue use of current testosterone replacement, as well as
Viagra or any other PDE5 inhibitors for 30 days.
We found this trial at
New York, New York 10028
New York, NY
Click here to add this to my saved trials